Dimensional Fund Advisors LP decreased its position in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 1.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 108,637 shares of the medical instruments supplier's stock after selling 1,879 shares during the quarter. Dimensional Fund Advisors LP owned about 0.52% of Mettler-Toledo International worth $128,280,000 as of its most recent filing with the SEC.
Several other large investors have also made changes to their positions in MTD. Zions Bancorporation National Association UT bought a new stake in shares of Mettler-Toledo International in the 1st quarter valued at approximately $43,000. Golden State Wealth Management LLC grew its stake in shares of Mettler-Toledo International by 583.3% in the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock valued at $48,000 after buying an additional 35 shares in the last quarter. Menard Financial Group LLC bought a new stake in shares of Mettler-Toledo International in the 4th quarter valued at approximately $67,000. Blue Trust Inc. grew its stake in shares of Mettler-Toledo International by 520.0% in the 1st quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock valued at $73,000 after buying an additional 52 shares in the last quarter. Finally, Farther Finance Advisors LLC lifted its holdings in Mettler-Toledo International by 39.1% in the 1st quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock worth $103,000 after purchasing an additional 25 shares during the last quarter. Institutional investors own 95.07% of the company's stock.
Insider Transactions at Mettler-Toledo International
In related news, CFO Shawn Vadala sold 300 shares of the company's stock in a transaction on Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total value of $376,227.00. Following the completion of the transaction, the chief financial officer directly owned 5,095 shares in the company, valued at approximately $6,389,588.55. This represents a 5.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Thomas P. Salice sold 1,062 shares of the company's stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the completion of the transaction, the director owned 283 shares of the company's stock, valued at $368,154.70. The trade was a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 2,889 shares of company stock valued at $3,603,054. Company insiders own 0.77% of the company's stock.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on MTD. Robert W. Baird boosted their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a report on Monday, August 4th. Bank of America boosted their target price on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a report on Thursday, June 26th. Jefferies Financial Group upgraded Mettler-Toledo International from an "underperform" rating to a "hold" rating and reduced their target price for the stock from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Citigroup boosted their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a report on Thursday. Finally, Evercore ISI reduced their target price on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a report on Monday, August 4th. Five analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat.com, Mettler-Toledo International currently has a consensus rating of "Moderate Buy" and an average price target of $1,311.11.
Get Our Latest Analysis on MTD
Mettler-Toledo International Price Performance
Shares of NYSE MTD traded down $31.57 during trading hours on Monday, reaching $1,289.88. The stock had a trading volume of 84,505 shares, compared to its average volume of 173,391. The business's fifty day moving average is $1,227.64 and its two-hundred day moving average is $1,186.72. The company has a market cap of $26.57 billion, a price-to-earnings ratio of 32.66, a PEG ratio of 3.97 and a beta of 1.34. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,521.01.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. The business had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.Mettler-Toledo International's revenue was up 3.9% on a year-over-year basis. During the same period in the prior year, the company posted $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Sell-side analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.
About Mettler-Toledo International
(
Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
See Also

Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report